<SEC-DOCUMENT>0000721371-19-000051.txt : 20190716
<SEC-HEADER>0000721371-19-000051.hdr.sgml : 20190716
<ACCEPTANCE-DATETIME>20190716080723
ACCESSION NUMBER:		0000721371-19-000051
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190712
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190716
DATE AS OF CHANGE:		20190716

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		19956224

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>july20198-k1.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s299C5AAF0DCCECB30E5BD208375CF19B"></a></div><div><div style="line-height:120%;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">WASHINGTON, DC 20549</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:18pt;"><font style="font-family:Arial Narrow;font-size:18pt;font-weight:bold;">FORM 8-K</font><font style="font-family:Arial Narrow;font-size:11pt;">&#160;</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): July 12, 2019</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">&#160;</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:24pt;"><font style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">(Exact Name of Registrant as Specified in Charter)</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:32%;"></td><td style="width:3%;"></td><td style="width:31%;"></td><td style="width:3%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Ohio</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1-11373</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31-0958666</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(State or Other Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(Commission</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(IRS Employer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">7000 Cardinal Place, Dublin, Ohio 43017</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices) (Zip Code)</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">(614) 757-5000</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">&#160;</font></div><div style="line-height:120%;padding-top:6px;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</font><font style="font-family:Arial Narrow;font-size:11pt;font-style:italic;">see</font><font style="font-family:Arial Narrow;font-size:11pt;">&#32;General Instruction A.2. below):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Title of each class</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Trading Symbol(s)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Common shares (without par value)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">CAH</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">New York Stock Exchange</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:93%;"></td><td style="width:7%;"></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Emerging growth company</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div><div><a name="s1B4D3F124615F59D06A0D208377E5CD5"></a></div><div style="line-height:120%;-sec-extract:summary;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;-sec-extract:summary;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item 2.02</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations and Financial Condition. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;On July 16, 2019,  Cardinal Health, Inc. (the &#8220;Company&#8221;) issued a news release that, among other things, affirmed that the Company expects to meet at least the midpoint of its non-GAAP earnings per share guidance range for the fiscal year ended June 30, 2019, which was reported in its May 9, 2019 earnings release.  A copy of the news release is furnished with this report as Exhibit 99.1.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item 5.02</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Jon L. Giacomin, Chief Executive Officer&#8212;Medical Segment, has notified the Company that he will leave the Company effective August 16, 2019.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item&#160;9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)&#160; </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Exhibits</font><font style="font-family:Arial Narrow;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.8515625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:81%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991news_release32.htm"><font style="font-family:Arial Narrow;font-size:10pt;">News release issued by the Company on July 16, 2019 and furnished with this Form 8-K</font></a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;-sec-extract:summary;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:44%;"></td><td style="width:3%;"></td><td style="width:5%;"></td><td style="width:2%;"></td><td style="width:4%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</font></div><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Registrant)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: July 16, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ Jessica L. Mayer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Name: Jessica L. Mayer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:30px;text-indent:-30px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Title: Chief Legal and Compliance Officer</font></div></td></tr></table></div></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">3</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991news_release32.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s926C9E53DACDA5A4C94EE1F0E7756909"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Exhibit 99.1</font></div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:38%;"></td><td style="width:18%;"></td><td style="width:18%;"></td><td style="width:12%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;"><img src="image0a09.jpg" alt="image0a09.jpg" style="height:68px;width:208px;"></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:9%;"></td><td style="width:37%;"></td><td style="width:5%;"></td><td style="width:12%;"></td><td style="width:37%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Media:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Brandi Martin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Investors: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Lisa Capodici</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">(614) 757-3383</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">(614) 757-5035</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">brandi.martin@cardinalhealth.com</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">lisa.capodici@cardinalhealth.com</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">CARDINAL HEALTH APPOINTS STEPHEN MASON </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">TO LEAD MEDICAL SEGMENT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Company Expects to Meet at Least the Midpoint of its Previously Announced Non-GAAP EPS </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Guidance for Fiscal Year &#8217;19</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">DUBLIN, OHIO, July 16, 2019 </font><font style="font-family:Arial;font-size:12pt;">&#8212; Cardinal Health (NYSE:CAH) today announced that Stephen Mason, President of the company&#8217;s Cardinal Health at-Home Solutions business, has been promoted to Chief Executive Officer of Cardinal Health&#8217;s Medical segment. Mr. Mason will succeed Jon Giacomin, who will be departing the company in mid-August to assume a CEO position at a privately-held company. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Mr. Mason is a highly accomplished 20-year veteran of Cardinal Health and has successfully led several businesses within both Cardinal Health&#8217;s Medical and Pharmaceutical segments. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Since 2016, Mr. Mason has overseen Cardinal Health at-Home Solutions, a component of the Medical segment that has delivered strong and consistent growth. Prior to that, he led Cardinal Health&#8217;s Kinray pharmaceutical distribution business. Mr. Mason also has deep experience leading sales, sales operations, and sourcing teams within the company&#8217;s Pharmaceutical Distribution business, including the Consumer Health, Sales Administration, Retail Independent Sales and Retail National Accounts teams.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Mike Kaufmann, CEO of Cardinal Health, commented, &#8220;We are pleased to name Steve Mason as the new CEO of our Medical segment. He is a proven leader who has consistently generated positive results in every business he has led within the company. With Steve at the helm, we look forward to building on the steady progress underway in the Medical segment as we continue to execute on our strategy to generate improved performance and long-term growth. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">&#8220;We want to thank Jon Giacomin for his many contributions to Cardinal Health over the years and wish him well,&#8221; concluded Mr. Kaufmann.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Mr. Mason added, &#8220;I am excited to take on responsibility for our Medical segment and to work with our talented team of leaders to continue to position our Medical businesses to best serve our customers and the healthcare community while, very importantly, meeting our long-term growth and profitability objectives. I am confident in the plans we have in place to deliver on our strategy.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Separately, Cardinal Health today affirmed that it expects to meet at least the midpoint of its non-GAAP EPS guidance range for fiscal year 2019, which was reported in its May 9, 2019 earnings release. As announced, the company will report its financial results for its fiscal fourth </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">quarter and year-end, as well as its outlook for fiscal 2020, on August 8, 2019, prior to market open. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;color:#333333;font-weight:bold;">About Cardinal Health </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company enhances supply chain efficiency for clinically proven medical products, pharmaceuticals and cost-effective solutions. To combat prescription drug misuse, the Cardinal Health Foundation and its education partners created Generation Rx, a national drug prevention&#160;education and awareness program. The Foundation actively supports an array of other solutions, including&#160;efforts to reduce&#160;opioid prescribing,&#160;promote&#160;drug take back and safe disposal and expand collaborative community work.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:5px;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">Cardinal Health is backed by nearly 100 years of experience with operations in nearly 46 countries. For more information, visit </font><font style="font-family:Arial;font-size:12pt;color:#0000ff;text-decoration:underline;">cardinalhealth.com</font><font style="font-family:Arial;font-size:12pt;">. Follow us on </font><font style="font-family:Arial;font-size:12pt;color:#0000ff;text-decoration:underline;">Twitter</font><font style="font-family:Arial;font-size:12pt;">, </font><font style="font-family:Arial;font-size:12pt;color:#0000ff;text-decoration:underline;">Facebook</font><font style="font-family:Arial;font-size:12pt;">&#32;and </font><font style="font-family:Arial;font-size:12pt;color:#0000ff;text-decoration:underline;">LinkedIn</font><font style="font-family:Arial;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Cautions Concerning Forward-Looking Statements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">This release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. For a list of these risks and uncertainties, please refer to Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This release reflects management's views as of July 16, 2019. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0a09.jpg
<TEXT>
begin 644 image0a09.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "< =D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]3@Z'HR_G
M2YS7G2_ ;PG9Z>;328;[0(?-\YAI.HSVVYL8)(1^<C'Y#TJG-\*?%.GLC:'\
M1]5MBAP(=5MXKV(1X("XPC$CCYF8DX.<DYKGYI]OZ_ ])4<--VC5M_BB_P!.
M8]1Z8XKD/&%OXX_>R^&;[1/X=EKJ=I-_P(F5)?Q ">V>]<+(WQO\.M&%C\,^
M*8%G(+#S+:>2+).3D[%) QQNP3_%C)J2_M*:IX:CW>,?AQKV@H"&>YM0+RWC
MC) WO( NT@YRN"< $9R*S=:/VKHZZ66UV^:@XU/1I_\ DKL_P.F'CSQYHK"/
M6/ 1U"-5"&ZT'4$F\U\9)$4HC*)UZL2.!SUJM_PTAX5TV:"W\10ZIX6N9BX"
M:O8O$N4.& < JW;E21\PYYJ70?VF/ASXB\E8O$=O:R2$J([T-"1]=P  ^IKO
M[>XTGQ-I?F0R6FIZ=<H5W*5EBE0Y!'H0:$^?6G.Y56DL/*V,PKCZ7C^?,CD)
M+SX<_&JUCMWFT?Q*$C9TC+(\T2$J&('WT!(7/3M[56E^"ME:R!O#_B'7O#WR
MA%CM+\RQ)&  $6.8.JC@= ",8! )!K^)OV:?AWXJ(>?P[!:2Y!W:?FWSC( (
M3 QS^@-<?J7P5^)/@T&X\$_$6\U!%?S/[/\ $'[XM\I!'FD'OC"X4<DY]8ES
MK6<+^AU4?J\DJ=#$N"_EFO=OZJZ^;2-HZ;\9_",R_9]2T/QM91^4NV[A>RN6
M X?!4E02/XB3SSCL:X_:8;P^,>-O!&N^%=O^MNEB^U6B9^Z#*H&2>!C;P3BN
M9/Q]^)'PUE9?'_@5[K3E"AM4TDDA H^9V&2IR67J4 ^;&>@[KPS^T?\ #?Q[
M8FWFU>VLVG0I+9ZLHB&"N65MWRD<X/)!P<9K-5(O2,^5]G_P?\SNJ8*NH^TK
MX55(_P U-_\ R-XKYQ.N\)_%CPAXVF\C1?$%C?7&2/(64+(<#)(0X) '<<5U
MZL&[BO'?&'[+/P]\9*TD>F#2+EL_O]+818)QSMY7H/3')]:\^NO 7QP^%<RO
MX=\3?\)MIJJ6:&^_UA.02,.Q//(&'X /3BM75JT_CC=>7^1P1R_ 8QVPM?DE
M_+4T_P#)EI]]CZC]:,8'%?,_@G]LJR6ZCTGQUHUUX=U9'V32K$QB7(!!9&.]
M#ST(;C!S@\?0?A_Q)I?BC3(=1TB_@U"RF&8YH'#*?8X[CT/2M:=>G5^%ZGG8
MW*L9E[7UBFTGL]T_1K0UJ***V/+"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *:R*W50?PIU% '$>+?@SX-\;"=M7\/
MV4]Q,<M=1Q".8G;M!+K@D@=,YZ#VKR77OV.K33WFO? OB?4_"VH,FP*)G:-U
M ^X64JXRP4DDL!CA>E?2%%83H4ZFKCJ>MALWQV$7+2JOE[/5?<[H^4;[6OVA
M?A>-UQ;6_BZQCWL9(HA,6''4+M?C/  [&M?PW^VYH4]U+9^)M OO#MS&[1OM
M;[0J%>"&&U65MV1C:<8Y/7'TL1G@C(KDO&WPK\*?$2,)KVBVU[(JE$N"NV5!
M@CAQ@C[Q..F3FN=T*L-:4_D]3V(9IEV*M',,*O\ %3]U_=LR3PK\2O"OCK*Z
M)K=EJ;[2QABE'F!00"Q0\@9(&<=ZXOQO^R[X!\: O_92Z/<[2JSZ7B#'3'R@
M;3T[KW->4?$+]B>6VO!J?@/5S:R1D2)97KL"C+DAHYEY!R%P&'!).X8 KCH?
MCM\6O@7JD.E^*[9]1MPVU$U)<^:BE0?+F7[QQCD[L%\D'-85*W*N7%4].^Z/
M7PF5*I+VV08SWOY)/EEZ=G^1N7WP5^+7P*87G@S7YM?TN%69K6($8S@M_HS,
MRDDY(*DDX/3.#M^ ?VUH[7_B6>.]'GL[^!_*DN[2/C<,AO,B)#(00 0,\D\+
MBN^^'O[6W@GQOY=O?S-X<OV49BU J(BV!G;+]T@$D#.TG!.!75^.O@[X*^,-
MBEU?64$\TT68-4LG DVL 58./O#@$9R/SI1IZ<V$GIVW15?&+G]AQ%A&I?SQ
M7++_ "D+=Z'\/?CIH;W7D:;K\#+Y/VR(*9HN<[0X^9",YQD=?>OGCQ1^RQXV
M^%NK-K?PYUJ>\15VB-9!%=*O4J>B2+D*<'';CC-97C#]F[Q[\%]2FU_P1J5U
MJ-I&#A[(%;I4+#"/&,B0="<#!*YVBNN^$?[:45SC3O'D0@E+@1ZG:Q?NR/\
MIJN<CG'*Y'/(&,G.<Z=22CB(\DN__!/0P^%QN#HRQ&2UEB*'6#U:7G'_ "MZ
M%[X7_MDQ372Z+X]L3I%_$WDO?QH1'N7(82QGYD(( XSDD\+BOIVRO8-1M8KF
MVFCN+>9!)'+$P9'4@$,".H(/4>M>5_$KX(^#OCII*ZE#+$E](@^SZSI[*^0N
M< X.'7).1[<$<5\Z:#XN\<?LB^)H]"UR!=2\.W;>;LC+&-QD;W@8@889&5.
M21TSNK=5:N&:5;WHOK_F>-++<#GD7/+5[.NMZ;V?^%_I^1]SBCV-<]X;\=:)
MXJ\+Q>(-.U"*32I(S(;AF"B, ?,'SC:1SD'&,5YQXV_:P\!>#7DMX[^36[M
M"8],42KR><.2$X')YKT)5J<8J4I:,^1H9;C,15=&E2;DMU;;U['M':JUU>06
M%O)/<2I#%&I=Y)&"JJ@9))/08[U\L6_QJ^,/QB5AX+\*QZ#ITBY%[.2^<AA\
MLKA5/(_A4X( /6NCTW]EG4_$Y%S\2?&VI>(&:19CIUO*T=LC@,#UZY!&"JH1
MSUS7.L0ZG\*-UWV/6J9+#!_[_7C!_P J]Z7X:+YL[[Q'^TE\._#*R"?Q);74
MJX/EV)-P3GIC9D'\ZJK\9M?UV9HO#'P]UB_V2;&N-6(TV$KMW$@N&<\X R@'
M)YXK-BNO@W\![@0K)I.GZE K9V@3W8P@R"1EE)!'!QG-<UJ'[8%OK5W+IG@+
MPIJ7B;4\X1FCV1!2,>80NYMH9E!W!1R?F'&8=;E=IS2?9?U^AU4\L55<V$PT
MI1_FF^6/X6M_X$=_#IWQ7\0PS/=:QH/A)2ZR01VMD]_*%(.8Y&=T7*Y4;E'S
M')&WH?1;!)+.RCBN+QKR91\T\@56?W(4 #\ *^?;>T^/_C^/?<WNE>";20QY
M2--\H&?F*CY^0!G!(!R!D=:Z"#]F6SUB2*?QMXKUOQA(&$C6]S.8;3S <!UA
M4_*0N5QDC#-Z\:0G)ZQB_G_7Z')B<+1IVC7KP7E!<S7ST3_\"9W&O?&CP1X9
M:1=1\3Z;#+'*8'B6X621'&<JR*25(P0<C@\50MOC9I6M),V@:7K.OJL?F1R6
M=@ZPS@$ ^7+)M0G)Q][L?0U:T[P/X ^%]N-0@TW1]#C@./MTPC1DW<8\UN1G
M..O?%8&N?M/?#;0-P;Q!%=NDIB9;.)I2",\\#!7CJ/454IN.LY)'-2PL*^F%
MHSJ>?_ 2?_I1Z1X?U2;6](@O)]/N=*FE!+6=WM\V/!Z-M+#GKP3UK2KQ6/\
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M5[Z4]+@XM*]AU%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3O5/5-*L]9LY;2^M8
M;NVE&V2&XC#HX]"I!S]*N=:.:/)@FXNZ=F?,_P 3OV+=$UY)+OPE<?V%>\8M
M)LO;/U_X$A/'()''W<G(\ T_Q1\3?V;-86PE-SIUNTA9;.[7S+2XVGYBASC!
MW9.P@\@GG%?HO63XD\+Z7XNTF;3-9LH;^PFQO@F7()!!!]B" :\VK@8R?/1?
M+(^ZR_BRO2A]6S**KTGTENO1_P"?WH\8^$O[6WAGQM:Q6WB&6'P[K.-KK,Y^
MSR8 ^97( 4'/W6Y&",GJ=3XS?LT^'OBG;SZC:*NE>(R"RWL/W9FV@*)5P<C@
M<CD?H?$OC1^QW?: )M7\%E]0T]07DTQ\M/$ ,Y1LDR X/R_>Z 9SQQ?PG_:2
M\5_"74$TS4VGU+1H&%O-IUYGSK95."(R3E67D;6XX XZUQRKRC^YQD;I]3Z2
MGD]*O_PI<,5VI+5P;U7EZ>3T?<GTWQ)\1OV4_$R6%XCR:7*Y(M9'+6MTBL-S
M1-_ W/)P#\P+ \5ZA\2OVL_!WBSX:K8R>'Y-5U#4K<B;3YFQ%:2 @9:0 $X/
MS*5&3@9VYKF?BA\9M8_:0OHO!_@O0%N+*18YVDNHE,ZMCYFR3MC5=X7<.>N#
MS@\!\1_@3XI^!K:9K5RMKJEIN4O/'%YL,4F3\CJXY4CN1@].#C/*ZE2G&4:+
MO3[[V/?I8/!8^I1J9K!4L7NHQE9RMM>VS?W_ )'+V?ACQ'8Z1I,>KS:AX?\
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MRRD9Y7CFI'8_M"?%J >=<IX4T^;<1D_9F"L P!VAI!CIV(Y!KWH+\/O@EIH
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MZDFWYBT444R HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEB3QM [ <\GIOAK^Q-JFLQK=^,+]M'@905LK/:\YR#]YB"J8XZ!L\],5]1>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;<0X_.)?OYVATBM$O\_F+11176?.!1110 4444 %%%% !1110 4444 %%%%
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MJGO<$^XN>N*=116QY@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK_8_*Q(R;=OD29Z9SD=<8[U]6VLOVBUAEQM\Q VW.<9 .,T")J***!A1110
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M&[^(GPC\$>*[^&&WO]<T.QU2XAM@1$DD]NDK*@))"@L0 23C&2>M?C+^V?\
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M%%% !1110 4444 %%%% !112$9H _G@_:6_Y.-^*O_8UZK_Z5RU^LG_!*_\
MY-%TG_L*WW_HROS$_;>\&_\ "#_M6?$FQ5+I8KG5I-1C:Z7!<7&)F*\ %0TC
M $ \  DD$G[\_P""17Q6L==^$.N^ I+BWCUC0KY[V*U&5EEM9L'S,$_,%D#*
M2H 4-&#RP)KH!]]T445('$?&;X8V_P 9OACX@\%7E[+IUIK,(MIKJ% SHF]6
M;:#QDA2 3D G)!Z'R#PA^QS^SW^SSX96]U70-!>"");>XUSQD\4PD+%1EC-B
M)&9@,;57DD# .*\S_P""E'[8WB#X!:?H?@WP3+]@\3ZW U[<:L1EK.V5]J"-
M2"I>1@X+$_*(R,$N"OYY_!G]G?XM_MH>)KV]LKJYU<6H2&\\2>([V22*(X^6
M,RMN=F .=J@D @D $9K41],_\%&OA;\"[_P+;>./AEX@\&V?B.QN(K:[T?PY
MJ-J([RV<E=ZV\.?WB,5.X;1M+YR0M>8_\$I/$ESH?[6%M8P1Q/%K.C7EC.T@
M)9$4+< I@@ [H$'((P3QG!%[]I#_ ()LW7[.?P.N?'U]\0(=9O;1K6*XTFWT
MDQQ>9*ZHX2<S$LJEC@F,%@!PI.!S?_!+[_D\3PO_ ->=_P#^DTE'09]"_P#!
M:+_FCO\ W&/_ &QKX0_9]^">J?M"_%C1/ VD7<%A<:@S-)=W )6"%%+R/M!&
MXA02%!&3@9&<C[O_ ."T7_-'?^XQ_P"V->9_\$?/^3E/$_\ V*5S_P"EEG1T
M ^[O@_\ L,_"']F_Q!9>--&COK?5M(LY%DU74]1)388BLLL@.$7*EB2 %&20
M !Q^)OQ(\?:G\4O'_B'Q?K)4ZGK5]-?3*C,4C,C%A&FXE@B@A5!)PJ@9XK^@
MGX]_\D+^(W_8N:C_ .DLE?SI4(#]O?V7_P!ASX=^ _@?H=EXN\#:3K'BO5-.
MCEUJ;5K))IHYI%+-"I8MY9C\PQ[HR"Q0-QQC\M_VTOV?X/V<?CQK'AG3$G'A
MZ=$OM+:X+,WD2#[A<J Q5@ZY&> ,DG)K]\Z_(K_@L)>V]Q\>O"<$4\4L]OX=
M59HT<%HR;B9@& .02"" <9!!Z4(#T'_@B[_S6+_N#_\ M]7#?\%BO^2X>"O^
MQ<'_ *535W/_  1=_P":Q?\ <'_]OJX;_@L5_P EP\%?]BX/_2J:CJ![E_P1
MU_Y(?XU_[&(_^DT-?*?_  56_P"3MK__ + ]E_Z"U?5G_!'7_DA_C7_L8C_Z
M30U\I_\ !5;_ ).VO_\ L#V7_H+4=0.U_P""9/[(_@[XX6OBGQCXYL%US3M-
MN%TVRTIY66(RE-\LD@ !.%:,)AL9+D@X4BE_P4R_9%\-_ BY\+^+_ ND-I7A
MS5I)+"^M49FAMKI5#Q;2SDCS$$F% P#"Q))8 ?0?_!'/_DA_C7_L8O\ VVAK
M5_X+!_\ )M'AK_L;K;_TBO:.H'S9_P $>]1NX_VAO%E@ES,ME/X6FGEMED(B
MDDCN[54=DS@LHDD )&0'8#&3G]%OVGOV;-+_ &H/"7AWPUK6J3Z;I6FZ[!J]
MTMM$&DNHXXIHS &+#R]WG9WX8@*0!DY'YQ?\$?/^3E_$O_8HW/\ Z6V5>M_\
M%'/V[/$7@;Q9<?"SX>7KZ+>6L:-K.MPG_2 TB!EMX3_RS 5@S./F)90I7!+'
M41]/P_ 3]FSX"Z/9:=K'A[P+HD5R"(9O%9MGFN3&JJY#W))8@%2P4XRP) SS
M^<?_  4@^'_PC\,^,O#&O_"C5O#L]OK4=T-3TOP[>13PVTT;(PDQ&[",2"8@
M*%4#RCC() Y7]G;]A_XE_M:1W/BV+4;2PT6YO9!=:]K-P\TUQ-O4S$(,O(YW
MLV6*AB""PR"4_;0_8M_X9#3P>W_"8_\ "6?\) ;P?\@O['Y'D>3_ --I-V[S
MO;&WOG@U ^H?^",FK7DVF_%;2VN&-A;RZ9<Q6^!M6207*NP[Y(BC!YQ\H]\\
M#_P6,_Y+5X&_[%__ -N9:[3_ ((N_P"N^+_^[I'\[VN+_P""QG_):O!'_8O'
M_P!*9:.HSL_^"+__ !\?%[_=TG^=Y7&_\%C/^2T^!_\ L7C_ .E,M=E_P1?_
M ./CXO?[ND_SO*XW_@L9_P EI\#_ /8O'_TIEHZB*$?_  1\^+$D:./%G@T!
M@#@W%WW_ .W>E_X<\_%C_H;/!G_@1=__ "/7ZYVO_'M%_N#^0J6B[&?B[^P+
MX.N_AY_P4$L/"E_-#<7^A76LZ9<36Q)B>2&"XB=E) )4E"02 <$9 /%?4?\
MP6"^)5[X?^$O@_P9:QLD'B749;F[N%D !BM%C(A*%3D-)/&^0P(,(&"&./"_
MV9_^4L/BG_L9O$__ +=UZ)_P6@_X]/A%_OZM_*SHZ@?3O_!/GX16'PH_9@\(
M2PPQ+J?B2TBUV^GB=F$K7"AXL[@,%83$I & 5.">IXW_ (*>? _2_B-^SSJ7
MBR.QC_X2?PIMO+>^4JCFVW@31.Q&63:Q<*"#N48(!8'YH^%_[$O[37BSX:>$
MM;T#XV_V3H6I:1:7EA8?\)'J<7V:WDA1XXMB1E5VJ57:I(&, D 5MZQ_P3M_
M:@\0Z9<Z;JOQNMM3TZY0QSVEYXBU26&5#U5T:(A@?0@T=1'MO_!*#QW)XH_9
MGET6:2>23P[JL]HID"A%CD F54(.2 78G(!R:^I&^$W@\_$@>/WT"S?QD+7[
M"NL.I:9(>FU<DA3@D9 !P2,X)!\1_8-_9=\2_LL> ?$>A^)M3TK4[G4M3%[%
M)I3RLBJ(E3#&1%.<J3P#QBOBGXA?M5?&W]LSXY7G@#X1:E>Z!X;^TR):?V7(
M]L_V6.11]LNKA0'C4D*VT8"[PGS$_,=0/UR'/6OR'TW2[3X/_P#!62+2_"MM
M%IFGOX@2(6J(/+C2[M5:947&%7,SA0  HP!@ 5VFA_\ !&;5KK2H)M;^*UI8
MZJV3/;V.AM=0J=QQME>>-FXP22BX)(YQD^'_  Q^#_\ PH/_ (**^$O 7]K_
M -N_V-K]G'_:'V;[/YOF0I+GR][;<>9C[QSC/&< 0S]#_P#@IM_R9GXU_P"N
M^G_^EL-<Y_P2@_Y-/B_[#EY_*.NC_P""FW_)F?C7_KOI_P#Z6PUSG_!*#_DT
M^+_L.7G\HZ70#QS_ (+0?\@[X2?]==5_E:5]O_LO_P#)M/PD_P"Q1TC_ -(H
MJ^(/^"T'_(.^$G_775?Y6E?;_P"R_P#\FT_"3_L4=(_](HJ.@'YS_P#!8[_D
ML'@/_L!/_P"E#U^DGP%^%.D_!3X1^&/".D10".PL84N+F& 0_;+C8OFW#+DX
M:1LL06.,@ D 5^;?_!8[_DL'@/\ [ 3_ /I0]?JYI?\ R#;7_KDO\A38'P-_
MP6(\':3<?!SP;XK>T7^W;37UTN.Z7AOL\MO<2NA]0&@0C/3+8QN.?R9K]@?^
M"P?_ ";1X:_[&ZV_](KVOQ^H0C^FBBBBI&%%%% !1110 4444 %%%% !1110
M 4'FBB@#\^/^"JG[+EWXZ\.Z?\4_"^GM=:MHL36^M6]M""\UD 62X)!!)B(8
M$;22L@)($>#^;/P4^-7BGX!>/K+Q=X2O?LNHVX,<L4@)ANH207AE4$;D8@$C
M(((!!! (_HMK\S_^"D/[''PR^'?PQU#XC>%=)E\.ZPMW&LEEI\@6QE\V:-23
M$5.S&YB!&5&3T(  H1U7AG_@L=X#NM+23Q!X"\1Z9J18AK?39K>]A"YX(D=H
MB2>XV#'J:KW'_!66T\;?$;P5X8\ >"YH;;5]7L[*^U#Q(X#I'+,(W6*&%R-V
M&1A(SD @@H>#7Y2UZY^R/H%OXF_:>^&FG73R1P-KUM(6A(#9C?S%Z@C&4&>.
MF<8/-%@/H3_@K=X:UG2_VBM+UB]DEET?5-&B&GEBY2,Q,RRQ@D;00Q#D*3@2
M*3@M73?\$R?VM? 'P3\+>*?!_CG4QX?^VZBFHV>I2J[Q29A"21N%0["OE(02
M3N,F,#:2?T&_:4_9V\&?M&> _P"Q_%UE(S6KF6RU&S*I=V;' 8Q.RL & &Y2
M"IP,C(!'\^='09]^?\%(OVVO#7QLT73/A[X O9M0T6UO?MVIZJJO'#=,L8$,
M<?S L@+R%@Z ;DC*G@UYE_P2^_Y/$\+_ /7G?_\ I-)6[J7[,/@?0?\ @GJW
MQ;2"\N_&>H36Z?:+FXS%;JUZL9$4:@ ?*IY;<?F;GL,+_@E]_P GB>%_^O._
M_P#2:2CH!]"_\%HO^:._]QC_ -L:\S_X(^?\G*>)O^Q2N?\ TLLZ],_X+1?\
MT=_[C'_MC7F?_!'S_DY3Q-_V*5S_ .EEG1T _8"OYU/CM\(-4^!'Q7\1>"-5
M+SRZ7<M'!=M$8A=VY.8IPN2 '4@X#'!)&2037]%=?%G_  4J_9S\%^-OA'K?
MQ'N[.6T\7>'[0M#?63*AN4& (YP5(=1G((PPZ!L9%) <K^SW_P %/OAGI7P9
M\*:9X_U;58?%NG64=C?2?8I;G[08@$68R98NSJ%9B3DL6. "!7YX?M5?'8_M
M'?&[7O&L=G)I^GW&RWL+6<J94MHQM3>5XW'EB 2 6P"P )\CK[4_X*"_LY^#
M/V<O 7PBTOPE:3>9>RZQ+>ZC>LLEU=LK683S'55!"@D*  !D\9))>P'L'_!%
MW_FL7_<'_P#;ZN&_X+%?\EP\%?\ 8N#_ -*IJ[G_ ((N_P#-8O\ N#_^WU<-
M_P %BO\ DN'@K_L7!_Z534=0/<O^".O_ "0_QK_V,1_])H:^4_\ @JM_R=M?
M_P#8'LO_ $%J^K/^".O_ "0_QK_V,1_])H:^4_\ @JM_R=M?_P#8'LO_ $%J
M.H'U7_P1S_Y(?XU_[&+_ -MH:U?^"P?_ ";1X:_[&ZV_](KVLK_@CG_R0_QK
M_P!C%_[;0UJ_\%@_^3:/#7_8W6W_ *17M'4#YE_X(^?\G+^)?^Q1N?\ TMLJ
M\L_X*,Z1>:7^V)X]>[@:!+R2VN8&./WD9MHE##!Z$HPYYX->I_\ !'S_ ).7
M\2_]BC<_^EME7UO_ ,%,/@#X3\?_  <U+Q_J$5U#XG\+V;_8[JUF"B6,Y;RI
M5((90Q+#&""3S@D4=1'G?[!/[<?PM\(_L_:/X+\8ZY'X3U7PZ9( ;T.\=Y')
M+)*)(RJG&-Y4J>00#DYX^5O^"A7[66C_ +3OCK0(/"T<_P#PBWAVWE6VN+J/
MRY+F:8H97"D;E4".-0"2<J3@9KY.K[3_ &@/V:? _P +?V#_ (:^-](LIY?%
M7B+4M-N+W4[N7>X2?3II7@0 !1&'52."W'+&F!Z]_P $7?\ 7?%__=TC^=[7
M%_\ !8S_ )+5X(_[%X_^E,M0?\$=]<O[?X[>,='CN772[SPRUY/:C&UYHKJ!
M(G/?*K/,!_OG/:I_^"QG_):O!'_8O'_TIEI=1G9_\$7_ /CX^+W^[I/\[RN-
M_P""QG_):? __8O'_P!*9:[+_@B__P ?'Q>_W=)_G>5QO_!8S_DM/@?_ +%X
M_P#I3+1U$?K+:_\ 'M%_N#^0J6HK7_CVB_W!_(5+4@?D9^S/S_P5@\4?]C-X
MG_\ ;NOIG_@JU\&9_B%\ [+Q7I\(EU+P==M=29D(_P!"F4+/A0,%@R0-DXPJ
M/C).#\S?LS_\I8O%'_8S>)__ &[K]:[VS@U&RN+6ZACN;6:-HY8)D#I(C##*
MRG@@@D$'L:K4#X9_X)F_M7>'/%?PITCX9:_K<5EXNT/-K8PW\NTWUL7S$L3N
MQWL@;8(Q@A54!< D?9/C[XD>%_A9X>?7?%NO6/A_2D?R_M-],$5W(+!%!Y9B
M%8A5!)"DXX-?D=_P4H_9A\#?L]^)?"]]X)MKO3H?$#7CW%A)/YEO"8_)*B($
M;E'[YA@L1@+C&.?DGP-HD'B;QMX>TBZ:2.VU'4K>SE>$@.J/*J$J2" <$XR#
M]*+ ?T*:E<6_QF^"]W/X?N%^R>*_#[OI\]RK(-ES;$Q,XP2!B121C(YXSQ7Y
M/_\ !+/XI^&OAA^T'JFG>)9+*P?Q!IITVQU2XW!EN!/&RP!LA564 DE@26BC
M (R0?UL^%?@VU^'?PV\->%["YN[NQT73H+*WFOI!),T<<:A=Q  ) P. !@
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#/__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
